title: Fatal pneumonitis after treatment with pegylated liposomal doxorubicin in a patient with metastatic breast cancer in complete remission.
authors.forename: Michael
authors.initials: M
authors.lastname: Mark
authors.forename: Beat
authors.initials: B
authors.lastname: Thürlimann
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D004317:Doxorubicin / Q000009:adverse effects / Q000031:analogs & derivatives*; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D017563:Lung Diseases, Interstitial / Q000139:chemically induced* / Q000401:mortality; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy / Q000473:pathology; D016066:Pleural Effusion, Malignant / Q000188:drug therapy / Q000209:etiology; D011092:Polyethylene Glycols / Q000009:adverse effects*; D012074:Remission Induction
chemical_list: D000970:Antineoplastic Agents; C506643:liposomal doxorubicin; D011092:Polyethylene Glycols; D004317:Doxorubicin